Chemoimmunotherapy Safe, Effective for Untreated Lung Cancer Brain Metastases
(MedPage Today) -- Chemoimmunotherapy for untreated lung cancer brain metastases delayed progression and use of whole-brain radiation, a prospective phase II study showed.
Atezolizumab (Tecentriq) plus carboplatin and pemetrexed led to a 12-week...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Alimta | Brain | Brain Cancers | Cancer | Cancer & Oncology | Hematology | Lung Cancer | Neurology | Study